Answers are grounded in this paper and cite their sources.
The efficacy and safety of biologics in patients with psoriasis and end‐stage renal disease is rarely reported. Here, we report a case of generalised pustular psoriasis (GPP) in a patient under haemodialysis successfully treated with spesolimab, with a dramatically positive response and excellent tolerance. This case report suggests that spesolimab is a good candidate for treating GPP, even in patients with haemodialysis.
No takes yet. Share an insight, caveat, or question.
Fujita et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: